Akebia Therapeutics, Inc.

The current price of AKBA is 1.39 USD — it hasn't changed in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Akebia Therapeutics, Inc. stocks are traded under the ticker AKBA.

Akebia Therapeutics, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.

AKBA stock is 7.89% volatile and has beta coefficient of 1.62. Check out the list of the most volatile stocks — is Akebia Therapeutics, Inc. there?

One year price forecast for Akebia Therapeutics, Inc. has a max estimate of 6.00 USD and a min estimate of 4.00 USD.

AKBA earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.09 USD resulting in a 5.88% surprise. The estimated earnings for the next quarter are −0.04 USD per share. See more details about Akebia Therapeutics, Inc. earnings.

Akebia Therapeutics, Inc. revenue for the last quarter amounts to ‪42.00 M‬ USD despite the estimated figure of ‪48.18 M‬ USD. In the next quarter revenue is expected to reach ‪55.39 M‬ USD.

Yes, you can track Akebia Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

AKBA net income for the last quarter is ‪613.00 K‬ USD, while the quarter before that showed ‪−14.49 M‬ USD of net income which accounts for 104.23% change. Track more Akebia Therapeutics, Inc. financial stats to get the full picture.

Today Akebia Therapeutics, Inc. has the market capitalization of ‪291.03 M‬, it has decreased by 3.16% over the last week.

No, AKBA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, AKBA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Akebia Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

AKBA reached its all-time high on Jun 20, 2014 with the price of 31.00 USD, and its all-time low was 0.24 USD and was reached on Oct 24, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 167.00 employees. See our rating of the largest employees — is Akebia Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Akebia Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Akebia Therapeutics, Inc. stock shows the neutral signal. See more of Akebia Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Akebia Therapeutics, Inc. future price: according to them, AKBA price has a max estimate of 6.00 USD and a min estimate of 4.00 USD. Read a more detailed Akebia Therapeutics, Inc. forecast: see what analysts think of Akebia Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Akebia Therapeutics, Inc. EBITDA is ‪−8.74 M‬ USD, and current EBITDA margin is −2.17%. See more stats in Akebia Therapeutics, Inc. financial statements.